If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMicrosaic Regulatory News (MSYS)

  • There is currently no data for MSYS

Director/PDMR Shareholding

13 Oct 2015 15:30

RNS Number : 1481C
Microsaic Systems plc
13 October 2015
 

Microsaic Systems PLC

("Microsaic" or the "Company")

 

Directors' Dealings

 

13 October 2015

 

Microsaic Systems plc (AIM: MSYS), the high technology company developing next generation mass spectrometry instruments, announces that it was informed on 13 October 2015 that on 12 October 2015, Mr Colin Nicholl, Chairman of the Company, purchased 50,000 ordinary shares of 0.25p each in the Company at a price of 27.65p per share. In addition, Mr Eric Yeatman, Non-Executive Director of the Company purchased 18,000 shares at a price of 27.65p on 13 October 2015. 

 

Following these transactions, Mr Nicholl holds 3,318,711 shares (approximately 5.2 per cent. of the Company's issued share capital) and Mr Yeatman holds 3,305,723 shares (approximately 5.2 per cent. of the Company's issued share capital).

 

Enquiries:

Microsaic Systems plc

via Citigate Dewe Rogerson

Colin Jump, CEO

Andrew Darby, FD

Numis Securities Limited

+44 (0)20 7260 1000

Stuart Skinner (Nominated Adviser)

James Serjeant (Broker)

Citigate Dewe Rogerson (Financial PR)

+44 (0)20 7282 2948/1068

Mark Swallow, Marine Perrier

 

About Microsaic Systems

 

Microsaic Systems plc is a high technology company developing and marketing next generation mass spectrometry (MS) instruments for the analysis of gaseous, liquid and solid samples. Microsaic has successfully miniaturised mass spectrometry into a desktop instrument by integrating the key MS components onto patented chip technologies (called ionchip®, spraychip® and vac-chip™). Microsaic's MS products retain the functionality of larger, conventional MS systems but are substantially smaller, lighter, consume less energy and have lower running costs. The Microsaic 4000 MiD® is the world's smallest MS system.

 

Mass spectrometry is a 'gold-standard' analytical technique used across many industry sectors, including pharmaceutical, diagnostics and healthcare, government, energy, utilities, environmental, food and drink, security and defence, and industrial chemicals - a combined market estimated to grow to $2.5 billion by 2017. Microsaic aims to introduce compact, deployable MS products, based on its core technology, into a series of these target markets.

 

Microsaic Systems was established in 2001 by a team including founders from Imperial College London, and was admitted to AIM in April 2011 under the symbol MSYS.

 

www.microsaic.com 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSFFIFLDFISEES
Date   Source Headline
26th Sep 20194:35 pmRNSPrice Monitoring Extension
23rd Sep 20197:00 amRNSInterim Results
4th Sep 20197:00 amRNSNotice of Results
12th Jun 20191:38 pmRNSAward of options
7th Jun 20197:00 amRNSDistribution Agreement with CM Corporation Ltd.
3rd Jun 20197:00 amRNSCost and time savings in manufacture of biologics
16th May 20192:06 pmRNSBoard Change
14th May 201912:00 pmRNSResult of AGM
14th May 201911:05 amRNSSecond Price Monitoring Extn
14th May 201911:00 amRNSPrice Monitoring Extension
14th May 20197:00 amRNSAGM Statement
2nd May 20197:00 amRNSDeepened collaboration with Chinese partner
12th Apr 20197:00 amRNSNotice of AGM and Posting of Annual Report
18th Mar 20197:00 amRNSOEM Agreement
11th Mar 20197:00 amRNSFinal Results
5th Mar 20197:00 amRNSInvestor Event
5th Mar 20197:00 amRNSMSYS jointly publishes bioprocessing data with MIT
19th Feb 20197:00 amRNSNotice of Results
11th Jan 20197:00 amRNSNew Protein Identification Product
19th Dec 201811:20 amRNSBioprocessing partnership update & trading update
7th Nov 20187:00 amRNSExclusive US and Canada Distribution Agreement
3rd Sep 20187:00 amRNSInterim Results
7th Aug 20187:00 amRNSNotice of Results
29th Jun 20184:12 pmRNSHolding(s) in Company
26th Jun 20182:04 pmRNSHolding(s) in Company
25th Jun 201810:10 amRNSDirectors' Interests
22nd Jun 201810:40 amRNSResult of GM, Completion of Fundraising & TVR
21st Jun 20187:00 amRNSDistribution Agreement with Amedis, spol. s ro.
13th Jun 20187:00 amRNSDistribution Agreement with Omicron Research Ltd.
6th Jun 20187:00 amRNSSuccessful Fundraising of £5.5 million
5th Jun 20184:46 pmRNSPrimaryBid.com Offer
5th Jun 20184:45 pmRNSFundraising
24th May 20187:00 amRNSDistribution Agreement with Stable Arm Sdn. Bhd.
9th May 20187:00 amRNSAgreement with Rightek Co., Ltd.
4th May 201811:25 amRNSResult of AGM
4th May 20187:00 amRNSAGM Statement
12th Apr 20187:00 amRNSMicrosaic signs Agreement with Knauer
6th Apr 20187:00 amRNSNotice of AGM and Posting of Annual Report
28th Mar 20187:00 amRNSAgreement with Unimicro Technologies Inc.
23rd Mar 20184:45 pmRNSHolding(s) in Company
21st Mar 20187:00 amRNSCommercial contract with CPI Innovation Services
5th Mar 20187:00 amRNSFinal Results
21st Feb 20187:00 amRNSNotice of Results
3rd Jan 20187:00 amRNSAward of Options
19th Dec 20177:00 amRNSDirectorate Change
13th Dec 20177:00 amRNSResearch agreement with global biopharma partner
28th Sep 20177:00 amRNSInterim Results
25th Sep 20177:00 amRNSAppointment of CEO
13th Sep 20177:00 amRNSMicrosaic to Exhibit at BioProcess International
14th Aug 20177:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.